PCOS Is Now PMOS And That One Letter Changes Everything

On May 12, 2026, published in The Lancet, that was finally, officially acknowledged. Polycystic ovary syndrome  PCOS  has been renamed polyendocrine metabolic ovarian syndrome, PMOS.

It is one letter on the surface. It is a profound correction underneath.

As a naturopathic doctor, I have always taught patients that a diagnosis is a starting point for understanding, not a verdict. But when the name itself is misleading, it corrupts the starting point entirely.

---

The word "polycystic" told women and far too many clinicians that this condition was about ovarian cysts. So when an ultrasound came back without visible findings, women were dismissed. "Your ovaries look fine," became the end of the conversation, when it should have been the beginning of a deeper investigation.

The reality is that what were called "cysts" in PCOS were never true cysts at all  they are underdeveloped follicles. And many women with this condition do not even have those. An estimated 70% of women with this condition have gone undiagnosed, and delayed diagnosis often means years without support for the insulin resistance, cardiovascular risk, and mental health impacts that sit at the very core of what this condition actually is.

What PMOS actually tells us

Let us break down what this new name communicates:

• Polyendocrine — More than one hormonal pathway is involved. Androgen excess, insulin signalling, neuroendocrine function, and ovarian hormones are all part of this picture.
  
• Metabolic — Insulin resistance is present in the vast majority of cases. This is a condition of metabolism, not just reproduction.
  
• Ovarian — Ovarian function still matters: ovulation, follicle development, and cycle regularity remain central. But they are one part of a much larger picture
  
• Syndrome — A constellation of features, not a single pathology. Two out of three diagnostic criteria still apply for a diagnosis

 
From a naturopathic standpoint, this is deeply validating. We have always looked at this condition through a systems lens  asking about blood sugar regulation, adrenal function, thyroid health, gut microbiome, inflammation, and stress physiology, not just cycle length and ultrasound findings. The new name invites conventional medicine to do the same.
 
What this means for how we investigate and treat

This is where the name change moves from symbolic to practical. If PMOS is fundamentally a polyendocrine metabolic condition, then assessment needs to reflect that. A proper workup should never begin and end with an ultrasound. It should include:

• Metabolic assessment: Fasting insulin, fasting glucose, HOMA-IR, full lipid panel, and HbA1c where indicated. Insulin resistance is the metabolic engine driving so many PMOS symptoms — and it is rarely tested as a first step
  
• Full hormone mapping: Free and total testosterone, DHEA-S, LH, FSH, prolactin, estradiol, progesterone (timed to cycle), and thyroid panel including TSH, free T3, free T4, and thyroid antibodies. The "polyendocrine" framing demands a polyendocrine investigation.
  
• Psychological screening: Anxiety and depression are significantly more prevalent in PMOS. This is not incidental  it is embedded in the biology. Screening for mental health must be a routine part of assessment, not an afterthought.
  
• Cardiometabolic risk markers: Blood pressure, waist circumference, inflammatory markers like hsCRP, and cardiovascular risk stratification. PMOS is a long-term health condition with real cardiovascular implications that deserve early attention.

  
A final thought

I do not think names are everything. But I think they matter more than medicine usually admits. A name shapes what clinicians look for, what patients understand about their own bodies, what researchers fund, and what insurance systems cover.

PMOS is not a perfect name. While some researchers have noted that keeping "ovarian" in the title forecloses conversation about whether this syndrome presents in people without ovaries. That conversation is worth having. But the shift away from "polycystic"  away from a word that was directing attention to the wrong place for over six decades  is an unambiguous step forward.

For the women who have spent years feeling unseen by a diagnosis that did not describe them, this matters. Words, at their best, are a form of recognition. PMOS says: We see the whole of what this is. And that is where good care begins.

IF YOU ARE NAVIGATING PMOS

Both PCOS and PMOS will be used interchangeably in clinics and health systems through approximately 2028, as terminology transitions globally. If you have questions about what a full metabolic and hormonal workup should include, or how nutrition, supplementation, and lifestyle interventions can support your care, reach out to a naturopathic doctor or integrative medicine practitioner who focuses on hormonal health​. You can also book a complimentary discovery call with me by clicking here. 

-- Dr. Shreya Mistry, ND